As a brain tumor survivor and the youngest winner of NYU Stern's business plan competition, Chris Mirabile is known for beating the odds. Throughout his career, Chris has pursued a lifelong passion “health and wellness“ with an emphasis on avoiding disease, and extending his healthy lifespan. According to independently verified third-party epigenetic, metabolomic, telomere, and physiological tests, he was able to reduce his biological age by 37% and his pace of aging by 31%. Now approaching a chronological age of 40, Chris' biology is by most accounts that of someone in his mid-twenties. In following his life-long passion and after more than a decade of research and experimentation, Chris founded NOVOS, the first nutraceutical company that targets the 12 biological causes of aging to increase longevity. NOVOS includes a Scientific Advisory Board of six of the world's top biologists and geneticists who study aging from Harvard, MIT, The Salk Institute, and more. With NOVOS, Chris created much more than a supplement company, he built the leading consumer biotech platform that leverages the latest science to help people take control of their healthspans and lifespans. NOVOS is a Public Benefit Corporation (PBC).


Don't miss out on more Redefining Medicine podcast - Subscribe today and say hello to us on social media! Email us at [email protected]


The views and opinions expressed on this program are those of the persons appearing on the program and do not necessarily reflect the views and opinions of The American Academy of Anti-Aging Medicine A4M/MMI™